Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael Lincoff

Showing results (161-170 of 353) with videos related to

Pageof 36
Sort By:
American Heart Journal|July 11, 2006
Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trialVivek Rajagopal, A Michael Lincoff, David J Cohen, et al.
Pharmacoeconomics|January 19, 2026
Development of Cardiovascular Risk Equations in People with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes Based on the SELECT TrialMartin Bøg, Anders Bo Bojesen, Scott Emerson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCAZachary S Yaker, A Michael Lincoff, Leslie Cho, et al.
The American Journal of Cardiology|June 29, 2004
Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventionsHitinder S Gurm, A Michael Lincoff, Neil S Kleiman, et al.
American Heart Journal|March 30, 2002
Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonistsWojciech Mazur, Grzegorz L Kaluza, Shelly Sapp, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 16, 2007
Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task ForceJohn McB Hodgson, Gregg W Stone, A Michael Lincoff, et al.
Atherosclerosis|March 8, 2002
Effect of anti-tumor necrosis factor-alpha polyclonal antibody on restenosis after balloon angioplasty in a rabbit atherosclerotic modelZhongmin Zhou, Michael A Lauer, Kai Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|August 17, 2023
Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with HypogonadismKarol M Pencina, Thomas G Travison, Glenn R Cunningham, et al.
Circulation|May 1, 2013
2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesJeffrey L Anderson, Cynthia D Adams, Elliott M Antman, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 15, 2009
Drug-eluting stent fracture and acute coronary syndromeAdnan K Chhatriwalla, Akin Cam, Samuel Unzek, et al.
Pageof 36

Showing results (161-170 of 353) with videos related to

Sort By:
Pageof 36
American Heart Journal|July 11, 2006
Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trialVivek Rajagopal, A Michael Lincoff, David J Cohen, et al.
Pharmacoeconomics|January 19, 2026
Development of Cardiovascular Risk Equations in People with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes Based on the SELECT TrialMartin Bøg, Anders Bo Bojesen, Scott Emerson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCAZachary S Yaker, A Michael Lincoff, Leslie Cho, et al.
The American Journal of Cardiology|June 29, 2004
Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventionsHitinder S Gurm, A Michael Lincoff, Neil S Kleiman, et al.
American Heart Journal|March 30, 2002
Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonistsWojciech Mazur, Grzegorz L Kaluza, Shelly Sapp, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 16, 2007
Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task ForceJohn McB Hodgson, Gregg W Stone, A Michael Lincoff, et al.
Atherosclerosis|March 8, 2002
Effect of anti-tumor necrosis factor-alpha polyclonal antibody on restenosis after balloon angioplasty in a rabbit atherosclerotic modelZhongmin Zhou, Michael A Lauer, Kai Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|August 17, 2023
Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with HypogonadismKarol M Pencina, Thomas G Travison, Glenn R Cunningham, et al.
Circulation|May 1, 2013
2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesJeffrey L Anderson, Cynthia D Adams, Elliott M Antman, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 15, 2009
Drug-eluting stent fracture and acute coronary syndromeAdnan K Chhatriwalla, Akin Cam, Samuel Unzek, et al.
Pageof 36